title: Narcolepsy, idiopathic hypersomnolence and related conditions.
authors: Respiratory Support and Sleep Centre, Papworth Hospital, Cambridge. Tim.Quinnell@papworth.nhs.uk
authors: Timothy G
authors: TG
authors: Quinnell
authors: Ian E
authors: IE
authors: Smith
mesh_terms: D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D002375:Catalepsy / Q000175:diagnosis / Q000188:drug therapy; D000697:Central Nervous System Stimulants / Q000627:therapeutic use*; D003913:Dextroamphetamine / Q000627:therapeutic use; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D020177:Idiopathic Hypersomnia / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008019:Life Style; D008774:Methylphenidate / Q000627:therapeutic use; D000077408:Modafinil; D009290:Narcolepsy / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D017286:Polysomnography; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D012978:Sodium Oxybate / Q000627:therapeutic use; D016896:Treatment Outcome
chemical_list: D000929:Antidepressive Agents, Tricyclic; D001559:Benzhydryl Compounds; D000697:Central Nervous System Stimulants; D003913:Dextroamphetamine; D006993:Hypnotics and Sedatives; D008774:Methylphenidate; D000077408:Modafinil; D017367:Selective Serotonin Reuptake Inhibitors; D012978:Sodium Oxybate